← FDA Drug Approvals (Drugs@FDA)
OSELTAMIVIR PHOSPHATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALVOGEN · Approved 2017-10-31
Drug application
- FDA Application #
ANDA208823- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OSELTAMIVIR PHOSPHATE
- Generic name
- OSELTAMIVIR PHOSPHATE
- Active ingredients
- OSELTAMIVIR PHOSPHATE
- Dosage form
- FOR SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ALVOGEN
- Manufacturer
- Alvogen Inc.
- First approval
- 2017-10-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown